Results 231 to 240 of about 9,284,227 (272)

Cinnamaldehyde/β-Cyclodextrin Inclusion Complex Enhances Physicochemical and Antioxidant Properties of Edible Orally Disintegrating Film. [PDF]

Foods
Zhou Y, Tian Y, Sha H, Liu C, Guo S, Wang Z.   +5 more
europepmc   +1 more source

Trend Analyses on Interventional Treatment of Atrial Fibrillation From 2016 to 2022: Insights From a Multicenter Hospital Database of Left Atrial Catheter Ablation Cases. [PDF]

Clin Cardiol
König S, Hohenstein S, Leiner J, Nitsche A, Baberg HT, Wiedemann M, Seyfarth M, Sause A, Staudt A, Reithmann C, Wunderlich C, Tebbenjohanns J, Shin DI, Steinborn F, Niehaus M, Bode K, Bollmann A.   +16 more
europepmc   +1 more source

Progress and challenges in seasonal influenza vaccination across 54 countries and areas in the WHO European Region, 2008/09-2022/23: a repeated cross-sectional ecological study. [PDF]

Lancet Reg Health Eur
Meslé MMI, Widdowson MA, Jorgensen P.
europepmc   +1 more source

Analytical validity of the INNOVANCE Antithrombin assay for the measurement of antithrombin activity at fitusiran clinical decision points. [PDF]

Res Pract Thromb Haemost
Freidel C, Boehm-Weigert M, Dahler C, Demissie M, Wang H, Liu M, Ali S, Chhabra ES.   +7 more
europepmc   +1 more source

Pharmacological Properties and the Impact of Caffeic Acid-Entrapped Liposomes on Triple-Negative Breast Cancer Cell Lines Exposed to Doxorubicin. [PDF]

Antioxidants (Basel)
Dejeu IL, Olteanu D, Clichici S, Baldea I, Soritău O, Frenț OD, Marian NA, Mureșan ME, Svera P, Marian E, Dejeu GE, Vicaș LG, Filip GA.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CA 15-3 Serum Levels in Ovarian Cancer

Oncology, 1988
Serum levels of CA 15-3, an antigen expressed by human breast carcinoma cells, were measured in 58 ovarian cancer patients, 24 patients with benign ovarian tumor and 62 patients with benign gynecological conditions. Abnormally high serum CA 15-3 levels were found in 41 of 58 patients (71%) with ovarian cancer.
Scambia S, BENEDETTI PANICI, PIERLUIGI, Baiocchi G, Perrone L, Greggi S, Di Roberto P, Mancuso S.   +6 more
openaire   +3 more sources

CA 15-3 as a tumor marker in gynecological malignancies

Gynecologic Oncology, 1988
Serum levels of CA 15-3 were measured in 778 samples from 270 patients with benign and malignant gynecological conditions. Malignant tumors were present in 180 patients including 58 cases with cancer of the ovary, 47 of the endometrium, 61 of the cervix, and 14 of the vulva.
G. Scambia, BENEDETTI PANICI, PIERLUIGI, G. Baiocchi, L. Perrone, S. Greggi, S. Mancuso   +5 more
openaire   +3 more sources

Analytical requirements and standardization of CA 15—3

Scandinavian Journal of Clinical and Laboratory Investigation, 1995
The CA 15-3 assay could play, probably in combination with cytokeratin markers, a role in the detection of early recurrence and in monitoring therapy in metastatic breast cancer patients. The CA 15-3 assay is, however, not useful for early detection of breast cancer and has no prognostic significance.
openaire   +2 more sources

Breast cancer and clinical utility of CA 15—3 and CEA

Scandinavian Journal of Clinical and Laboratory Investigation, 1995
This manuscript summarizes the experiences with CA 15-3 and CEA obtained in 8,000 breast cancer patients. These markers were usually in normal range (CEA < 6 micrograms/L, CA 15-3 < 40 U/L) before surgery and increased only before the development of distant metastases. 80% of all patients with metastases had elevated marker levels several months before
W, Jäger, S, Krämer, V, Palapelas, L, Norbert   +3 more
openaire   +2 more sources